C-CR5

the IC50 of C-CR5 was found to be 16.92 ± 0.47 μg/mL (29.86 ± 0.83 μM). Figure 3 caption: IC50 = 16.92 ± 0.47 μg/mL; (29.86 ± 0.83 μM), n = 3.

C-CR5 showed very high activity from 73% to 83% under the same concentration condition [25–400 μg/mL].

C-CR5 showed very high activity from 73% to 83% under the same concentration condition [25–400 μg/mL].

IC50 of C-CR5 was found to be 16.92 ± 0.47 μg/mL (29.86 ± 0.83 μM).

the IC50 of C-CR5 was identified as 104.2 ± 5.3 μg/mL (184.0 ± 9.4 μM). Figure 4 caption: IC50 = 104.2 ± 5.3 μg/mL; (184.0 ± 9.4 μM), n = 3.

IC50 of C-CR5 was identified as 104.2 ± 5.3 μg/mL (184.0 ± 9.4 μM).

C-CR5 showed a rapid increase from 30.91% to 97.79% in the same concentration section [50–800 μg/mL].

C-CR5 showed a rapid increase from 30.91% to 97.79% in the same concentration section [50–800 μg/mL].

the expression level of C-CR5 decreased sharply from 200 μg/mL to 63.31%.

decreased to 7.78% at 400 μg/mL, showing almost complete inhibitory effects.

As a result of treating the RAW 264.7 macrophages with L-CR5 and C-CR5 at a concentration of 6.25–400 μg/mL, cell viability was maintained at 95% or more in all treatment groups.